These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23504914)

  • 1. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma.
    Saito Y; Yoshida M; Ushiku T; Omura G; Ebihara Y; Shimono T; Fukayama M; Yamasoba T; Asakage T
    Cancer; 2013 Jun; 119(11):2005-11. PubMed ID: 23504914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.
    Fischer CA; Kampmann M; Zlobec I; Green E; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Ann Oncol; 2010 Oct; 21(10):1961-1966. PubMed ID: 20423915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
    Wang Z; Xia RH; Ye DX; Li J
    PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
    Lin CM; Lin LW; Chen YW; Ye YL
    Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of oropharyngeal cancer and p16 expression.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2011 Sep; 131(9):1008-11. PubMed ID: 21542673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.
    Cooper T; Biron VL; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):250-6. PubMed ID: 25554966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenting symptoms and clinical findings in HPV-positive and HPV-negative oropharyngeal cancer patients.
    Carpén T; Sjöblom A; Lundberg M; Haglund C; Markkola A; Syrjänen S; Tarkkanen J; Mäkitie A; Hagström J; Mattila P
    Acta Otolaryngol; 2018 May; 138(5):513-518. PubMed ID: 29161981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma.
    Saito Y; Yoshida M; Omura G; Kobayashi K; Fujimoto C; Ando M; Sakamoto T; Asakage T; Yamasoba T
    Jpn J Clin Oncol; 2015 Sep; 45(9):828-36. PubMed ID: 26056326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
    Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
    Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.